Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Guillaume Luxardi, PhD"'
Autor:
Jonathan W. Riess, MD, Matthew S. Lara, BS, Miguel Lopez de Rodas, MD, Guillaume Luxardi, PhD, Samantha Herbert, MSPH, Michiko Shimoda, PhD, Karen Kelly, MD, Alexander Meerlev, PhD, Elizabeth Moore, MD, Laurel Beckett, PhD, Arta Monjazeb, MD, PhD, Kurt Schalper, MD, PhD, Emanual Maverakis, MD, David R. Gandara, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100706- (2024)
Introduction: EGFR-mutated NSCLC is minimally responsive to programmed cell death protein 1 or programmed death-ligand 1 blockade. We evaluated the safety, tolerability, and immunomodulatory effects of the EGFR tyrosine kinase inhibitor (TKI) afatini
Externí odkaz:
https://doaj.org/article/863cfd19d5dc48c7a90762bd86354f28
